P‐MAPK11 is the primary activation form of MAPK11, and the protein expression level of RUNX2, MAPK11 and P‐MAPK11 was analysed in 32 pairs of ccRCC tissues and neighbouring normal tissues to investigate the clinical role of ccRCC. This evidence concerns the gene RUNX2 and nonpapillary renal cell carcinoma.